Drone Flights Give Scientists Better Data on Vegetation in the Arctic Tundra

Scientists use various satellite and airborne systems to study how vegetation changes in response to climate change. However, these systems have low resolution that makes it hard to identify detailed patterns. This is especially true in the Arctic due to the region’s highly mixed vegetation. Now, scientists have adopted unoccupied aerial systems—also known as drones—for high-resolution vegetation monitoring.

UNH-led Atlantic Marine Energy Center Receives Nearly $10 Million From DOE

The new Atlantic Marine Energy Center (AMEC), led by the University of New Hampshire in partnership with several East Coast universities, has been awarded $9.7 million over four years from the U.S. Department of Energy (DOE). The center will focus on research and development to address ongoing needs for sustainable renewable ocean energy. It will be one of only four National Marine Renewable Energy Centers (NMREC) in the country.

Misterio cósmico: estudio de ALMA confirma factores que despojan a las galaxias del gas incubador de estrellas

Gracias al Atacama Large Millimeter/submillimeter Array (ALMA), un equipo de astrónomos que estaba observando el Universo cercano acaba de terminar el mayor estudio de alta resolución realizado a la fecha sobre el material incubador de estrellas presente en cúmulos de galaxias. De esa forma, los científicos buscaron respuesta a un antiguo misterio de la astrofísica: ¿qué provoca la muerte de las galaxias? Los resultados de esta investigación, que proporcionan los indicios más fehacientes hasta ahora de que los ambientes extremos inciden considerablemente en las galaxias, se publicarán en la próxima edición de The Astrophysical Journal Supplement Series.

A Cosmic Whodunit: ALMA Study Confirms What’s Robbing Galaxies of Their Star-Forming Gas

Astronomers examining the nearby Universe with the help of the Atacama Large Millimeter/submillimeter Array (ALMA) have just completed the largest high-resolution survey of star-forming fuel ever conducted in galaxy clusters. But more importantly, they’re tackling a long-standing mystery in astrophysics: what’s killing galaxies? The research, which provides the clearest evidence to date that extreme environments in space have severe impacts on the galaxies within them, will be published in an upcoming edition of The Astrophysical Journal Supplement Series.

Mechanisms of addiction: Psychology professor receives NIH grant for brain research

A five-year, $2.59 million grant from the National Institutes of Health will allow a psychology professor at Binghamton University, State University of New York to study the mechanisms of addiction.

Antibiotic resistance outwitted by supercomputers

Scientists may have made a giant leap in fighting the biggest threat to human health by using supercomputing to keep pace with the impressive ability of diseases to evolve.
A new study by an international team, co-led by Dr Gerhard Koenig from the University of Portsmouth, tackled the problem of antibiotic resistance by redesigning existing antibiotics to overcome bacterial resistance mechanisms.

3D simulations improve understanding of energetic-particle radiation and help protect space assets

A team of researchers used 3D particle simulations to model the acceleration of ions and electrons in a physical process called magnetic reconnection. The results could contribute to the understanding and forecasting of energetic particles released during magnetic reconnection, which could help protect space assets and advance space exploration.

Patients taking Rituximab Could Benefit from Third COVID-19 Vaccine Dose

New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, shows patients using rituximab were able to produce antibodies against COVID-19 after receiving a third vaccine dose, even if there was no development of the antibody after the first two.

DOE grants will help advance AI techniques to address data challenges

Argonne scientists have received two high-profile grants from the U.S. Department of Energy that will help scientists at the U.S. National Laboratories take advantage of the latest developments in machine learning technology.

Black People with Systemic Sclerosis May Have More Severe Disease, Worse Prognosis

New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, shows that Black people living with systemic sclerosis may have more severe disease and worse prognosis than patients in other racial or ethnic groups.

Study Finds Cycling JAK Inhibitors Effective Option for Patients with Difficult-to-Treat RA

New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, shows that people with difficult-to-treat rheumatoid arthritis who do not have success with JAK inhibitor can achieve success either cycling to other JAKi or switching to a biologic drug.

Ultra-Low Dose Rituximab Controls Disease Activity for Most RA Patients in New Study

New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, shows the majority of rheumatoid arthritis patients on an ultra-low dose of rituximab maintained low disease activity for up to 4 years, and rarely needed to switch to other biologic drugs.

Virtual Exercise Effective for People with Arthritis and Helps Them Stay Socially Connected Too

New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, found that a virtual exercise program can be safe for people with musculoskeletal conditions, improved their health outcomes, and helped them feel more socially connected.

Higher Doses and Longer Use of Hydroxychloroquine Increase Risk of Severe Eye Complication

New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, shows that higher doses, longer duration of use, chronic kidney disease and Asian race could all be risk factors for retinopathy in people using hydroxychloroquine for rheumatoid arthritis.